Abstract
In a 6-volunteer cross-over study the pharmacokinetics of 3 erythromycin preparations were compared. A single oral dose of 500 mg of each preparation was administered at each occasion and the levels measured in timed samples of plasma and saliva. Markedly higher blood concentrations of the estolate and propionate were obtained compared to the stearate. Comparison of serum and plasma concentration of the drugs from each split sample showed no significant differences. Plasma concentrations always exceeded those in saliva but for any one preparation a similar ratio was obtained at different times. This may be useful to ascertain compliance and to measure concentration of the compounds where direct measurement in plasma is not practicable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Lacey R. W. A new look at erythromycin. Postgrad Med J. 1977 Apr;53(618):195–200. doi: 10.1136/pgmj.53.618.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stephens V. C., Pugh C. T., Davis N. E., Hoehn M. M., Ralston S. A study of the behavior of propionyl erythromycin in blood by a new chromatographic method. J Antibiot (Tokyo) 1969 Nov;22(11):551–557. doi: 10.7164/antibiotics.22.551. [DOI] [PubMed] [Google Scholar]
- Tardrew P. L., Mao J. C., Kenney D. Antibacterial activity of 2'-esters of erythromycin. Appl Microbiol. 1969 Aug;18(2):159–165. doi: 10.1128/am.18.2.159-165.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiegand R. G., Chun A. H. Serum protein binding of erythromycin and erythromycin 2'-propionate ester. J Pharm Sci. 1972 Mar;61(3):425–428. doi: 10.1002/jps.2600610322. [DOI] [PubMed] [Google Scholar]